SCHEMBL6312223

SCHEMBL6312223

Cc1c(C2CCCCC2)c(Cl)n2c(nc3ccccc32)c1C#N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 7/20 0.60
MAPT P10636 4/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
LMNA P02545 3/20 0.60
RAB9A P51151 2/20 0.60
NPC1 O15118 1/20 0.60
MDM2 Q00987 1/20 0.60
HSP90AA1 P07900 1/20 0.59
KMT2A Q03164 5/20 0.57
HPGD P15428 5/20 0.57
HTT P42858 3/20 0.57
KDM4E B2RXH2 8/20 0.53
ALDH1A1 P00352 7/20 0.53
GAA P10253 5/20 0.53
GLA P06280 4/20 0.53
POLB P06746 3/20 0.53
XBP1 P17861 1/20 0.53
HIF1A Q16665 2/20 0.50
MEN1 O00255 4/20 0.48
HK1 P19367 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6312096 0.82 HSP90AA1 (0.57) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6312781 0.80 MAPT (0.73) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL14728265 0.79 NPSR1 (0.53) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6319413 0.78 MEN1 (0.49) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6319416 0.78 HIF1A (0.51) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6309843 0.77 MAPT (0.70) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6310420 0.77 NPSR1 (0.74) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6310321 0.75 NPSR1 (1.00) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6310647 0.75 MAPT (0.67) NPSR1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL6310360 0.75 MAPT (0.67) NPSR1MAPTSMN1; SMN2LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239362-A1 Nonwoven binders with high wet/dry tensile strength ratio WACKER POLYMERS, L.P. 2005-10-27 US disclosed
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 NPSR1 1531/4885MAPT 1694/4885SMN1; SMN2 2642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.